Latest filing published 01 May 2018 for CAS MEDICAL SYSTEMS INC, €6,388.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Acuta Capital Fund, LP: trading record in brief
Acuta Capital Fund, LP has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CAS Medical Systems Inc and Iridex Corp. Between 4 January 2017 and 19 March 2018, the trades on record add up to 145 filings.
On the market, this insider has only ever bought: 145 purchases, €2.3M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2018, the count stands at 145 purchases and no sales.
In size, the median ticket on the buying side is €4,354.
The latest filing, published on 1 May 2018, reports an open-market purchase of €6,388 in CAS Medical Systems Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Acuta Capital Fund, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,320 shares@ US$1.177Common StockSEC:0001209191-18-027153:0Canonical exit: 23 Oct 2017 (T+90)
- 59,228 shares@ US$1.1971Common StockSEC:0001209191-18-027153:1Canonical exit: 24 Oct 2017 (T+90)
- 2,088 shares@ US$1.1838Common StockSEC:0001209191-18-027153:2Canonical exit: 25 Oct 2017 (T+90)
- 10,287 shares@ US$1.1876Common StockSEC:0001209191-18-027153:3Canonical exit: 26 Oct 2017 (T+90)
- 1,340 shares@ US$1.185Common StockSEC:0001209191-18-027153:4Canonical exit: 29 Oct 2017 (T+90)
- 3,400 shares@ US$1.18Common StockSEC:0001209191-18-027153:5Canonical exit: 30 Oct 2017 (T+90)
- 1,292 shares@ US$1.1753Common StockSEC:0001209191-18-027153:6Canonical exit: 31 Oct 2017 (T+90)
- 4,051 shares@ US$1.171Common StockSEC:0001209191-18-027153:7Canonical exit: 1 Nov 2017 (T+90)
- 2,624 shares@ US$1.1789Common StockSEC:0001209191-18-027153:8Canonical exit: 2 Nov 2017 (T+90)
- 2,311 shares@ US$1.1813Common StockSEC:0001209191-18-027153:9Canonical exit: 5 Nov 2017 (T+90)
- 26,384 shares@ US$0.9856Common StockSEC:0001209191-18-027153:10Canonical exit: 6 Nov 2017 (T+90)
- 4,080 shares@ US$0.9917Common StockSEC:0001209191-18-027153:11Canonical exit: 7 Nov 2017 (T+90)
- 8,656 shares@ US$0.9823Common StockSEC:0001209191-18-027153:12Canonical exit: 8 Nov 2017 (T+90)
- 5,440 shares@ US$1.0018Common StockSEC:0001209191-18-027153:13Canonical exit: 9 Nov 2017 (T+90)
- 2,720 shares@ US$0.9649Common StockSEC:0001209191-18-027153:14Canonical exit: 13 Nov 2017 (T+90)
- 333 shares@ US$0.99Common StockSEC:0001209191-18-027153:15Canonical exit: 14 Nov 2017 (T+90)
- 4,284 shares@ US$0.9648Common StockSEC:0001209191-18-027153:16Canonical exit: 15 Nov 2017 (T+90)
- 1,565 shares@ US$0.9909Common StockSEC:0001209191-18-027153:17Canonical exit: 16 Nov 2017 (T+90)
- 816 shares@ US$0.985Common StockSEC:0001209191-18-027153:18Canonical exit: 20 Nov 2017 (T+90)
- 5,576 shares@ US$0.9595Common StockSEC:0001209191-18-027153:19Canonical exit: 21 Nov 2017 (T+90)
- 2,720 shares@ US$0.9525Common StockSEC:0001209191-18-027153:20Canonical exit: 22 Nov 2017 (T+90)
- 1,088 shares@ US$0.9279Common StockSEC:0001209191-18-027153:21Canonical exit: 27 Nov 2017 (T+90)
- 2,464 shares@ US$0.8857Common StockSEC:0001209191-18-027153:22Canonical exit: 6 Dec 2017 (T+90)
- 222 shares@ US$0.90Common StockSEC:0001209191-18-027153:23Canonical exit: 7 Dec 2017 (T+90)
- 2,070 shares@ US$0.6207Common StockSEC:0001209191-18-027153:24Canonical exit: 13 Mar 2018 (T+90)
25 of 145 declarations
